p35/Cdk5 pathway mediates soluble amyloid-β peptide-induced tau phosphorylation in vitro

被引:91
作者
Town, T [1 ]
Zolton, J [1 ]
Shaffner, R [1 ]
Schnell, B [1 ]
Crescentini, R [1 ]
Wu, YJ [1 ]
Zeng, J [1 ]
DelleDonne, A [1 ]
Obregon, D [1 ]
Tan, J [1 ]
Mullan, M [1 ]
机构
[1] Univ S Florida, Roskamp Inst, Dept Psychiat, Tampa, FL 33613 USA
关键词
Alzheimer's disease; amyloid-beta; tau; N2a cells; calpain; calcium;
D O I
10.1002/jnr.10299
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is pathologically characterized by deposition of amyloid-beta peptides (Abeta) as senile plaques and by the occurrence of neurofibrillary tangles (NFTs) composed primarily of hyperphosphorylated tau protein. Activation of cyclin-dependent kinase 5 (Cdk5) via its potent activator p25 has recently been shown to promote phosphorylation of tau at AD-specific phosphoepitopes, and increased cleavage of p35 to p25 has been demonstrated in AD patients, suggesting that Cdk5 may represent a pathogenic tau protein kinase. We were interested in the potential effect of soluble forms of Abeta on Cdk5-mediated AD-like tau phosphorylation, insofar as previous studies of human biopsies and aged canine and primate brains have shown that dystrophic neurites appear before the formation of neuritic plaques. We transfected N2a cells with a p35 vector (N2a/p35 cells) and, after differentiation, challenged these cells with Abeta(1-42) peptide in soluble form (sAbeta(1-42)). Results show that sAbeta(1-42) at relatively low levels (1-5 muM) dose-dependently increases tau phosphorylation at AD-specific phosphoepitopes in differentiated N2a/p35 cells compared with controls, an effect that is blocked by antisense oligonucleotides against p35. sAbeta(1-42)-induced tau phosphorylation is concomitant with an increase in both p25 to p35 ratio and Cdk5 activity (but not protein levels). Additionally, blockade of L-type calcium channels or inhibition of calpain completely abolishes this effect. Taken together, these data indicate that sAbeta is a potent activator of the p25/Cdk5 pathway, resulting in promotion of AD-like tau phosphorylation in vitro. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:362 / 372
页数:11
相关论文
共 42 条
[1]   A cdk5-p35 stable complex is involved in the β-amyloid-induced deregulation of cdk5 activity in hippocampal neurons [J].
Alvarez, A ;
Muñoz, JP ;
Maccioni, RB .
EXPERIMENTAL CELL RESEARCH, 2001, 264 (02) :266-274
[2]  
ATLAS D, 1981, P NATL ACAD SCI USA, V78, P237
[3]  
Braak H, 1998, J NEURAL TRANSM-SUPP, P127
[4]   Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer's disease [J].
Braak, H ;
Braak, E ;
Bohl, J ;
Reintjes, R .
NEUROSCIENCE LETTERS, 1996, 210 (02) :87-90
[5]   TAU-PROTEIN FUNCTION IN LIVING CELLS [J].
DRUBIN, DG ;
KIRSCHNER, MW .
JOURNAL OF CELL BIOLOGY, 1986, 103 (06) :2739-2746
[6]  
Flaherty DB, 2000, J NEUROSCI RES, V62, P463, DOI 10.1002/1097-4547(20001101)62:3<463::AID-JNR16>3.0.CO
[7]  
2-7
[8]   Tricresyl phosphate inhibits the formation of axon-like processes and disrupts neurofilaments in cultured mouse N2a and rat PC12 cells [J].
Flaskos, J ;
McLean, WG ;
Fowler, MJ ;
Hargreaves, AJ .
NEUROSCIENCE LETTERS, 1998, 242 (02) :101-104
[9]   Structure of tau protein and assembly into paired helical filaments [J].
Friedhoff, P ;
von Bergen, M ;
Mandelkow, EM ;
Mandelkow, E .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1502 (01) :122-132
[10]   Site-specific dephosphorylation of tau of apolipoprotein E-deficient and control mice by M1 muscarinic agonist treatment [J].
Genis, I ;
Fisher, A ;
Michaelson, DM .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (01) :206-213